The Study of the Antimicrobial Resistance of Helicobacter Pylori in Shandong Province
NCT04029415 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1800
Last updated 2019-07-23
Summary
The antimicrobial resistance of helicobacter pylori in Shandong province was analyzed by helicobacter pylori antibiotic sensitivity test.And the map of antimicrobial resistance of helicobacter pylori was constructed to provide clinical guidance for selecting effective eradication program and improve the eradication rate.
Conditions
- Helicobacter Pylori
Sponsors & Collaborators
-
Shandong University
lead OTHER
Principal Investigators
-
Xiuli Zuo, MD,PhD · Qilu Hospital of Shandong University
-
Tian Ma, MD · Qilu Hospital of Shandong University
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-01
- Primary Completion
- 2020-09-30
- Completion
- 2020-09-30
Countries
- China
Study Locations
More Related Trials
-
Optimal Duration of Antimicrobial Susceptibility Test (AST) Guided Rescue Therapy for Helicobacter Pylori Infection
NCT02934048 ·Status: UNKNOWN ·Phase: PHASE4
-
A Multi-center Study for Eradication of Helicobacter Pylori With Triple Therapy Using Clarithromycin
NCT02923856 ·Status: UNKNOWN ·Phase: NA
-
Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment
NCT02988089 ·Status: UNKNOWN ·Phase: PHASE4
-
Helicobacter Pylori Antibiotic Susceptibility Testing of Korea
NCT02961296 ·Status: UNKNOWN
-
Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection
NCT03658746 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection
NCT04991584 ·Status: UNKNOWN ·Phase: NA
-
Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the First-line Eradication of H. Pylori
NCT03556254 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Different Acid Suppressors in Bismuth-containing Quadruple Therapy Against Helicobacter Pylori
NCT05301725 ·Status: COMPLETED
-
Helicobacter Pylori First-line Treatment Containing Tetracycline in Patients Allergic to Penicillin
NCT05129176 ·Status: UNKNOWN ·Phase: PHASE4
-
Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.
NCT03571230 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of 14-day Concomitant Therapy for Difficult-to-Treat Helicobacter Pylori Infection
NCT05126121 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection
NCT05718609 ·Status: UNKNOWN ·Phase: PHASE4
-
Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection
NCT04332848 ·Status: RECRUITING ·Phase: PHASE4
-
The Impact of Antibiotics MIC Value on the Efficacy of Treatment Regimens for Helicobacter Pylori Infection.
NCT03583476 ·Status: UNKNOWN
-
Helicobacter Pylori Resistance
NCT05019586 ·Status: COMPLETED
-
Community-based Helicobacter Pylori Eradication
NCT00155389 ·Status: UNKNOWN ·Phase: PHASE4
-
Optimization of Vonoprazan-based Dual Therapy for Helicobacter Pylori
NCT05649540 ·Status: COMPLETED ·Phase: PHASE4
-
Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment
NCT05250050 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Dual Therapy for Helicobacter Pylori Eradication
NCT05469685 ·Status: COMPLETED ·Phase: PHASE4
-
Study the Effect of Probiotics Combined With Bismuth Quadruple Rescue Therapy on H Pylori Infective Patients
NCT03297242 ·Status: UNKNOWN
-
Helicobacter Pylori Eradication and Follow-up
NCT05061732 ·Status: RECRUITING ·Phase: PHASE4
-
Susceptibility-Guided Sequential Therapy for Helicobacter Pylori Infection
NCT05549115 ·Status: UNKNOWN ·Phase: NA
-
Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection
NCT05332444 ·Status: RECRUITING ·Phase: PHASE4
-
The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori
NCT02349685 ·Status: COMPLETED ·Phase: NA
-
A Multi-center Study for Eradication of Refractory Helicobacter Pylori
NCT02741414 ·Status: UNKNOWN ·Phase: NA